Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease

Autor: Peikert, Kevin, Glaß, Hannes, Federti, Enrica, Matte, Alessandro, Pelzl, Lisann, Akgün, Katja, Ziemssen, Tjalf, Ordemann, Rainer, Lang, Florian, Patients, The Network for Translational Research for Neuroacanthocytosis, Franceschi, Lucia De, Hermann, Andreas

Publikováno v: Journal of Personalized Medicine 11(5), 392-(2021). doi:10.3390/jpm11050392
Journal of Personalized Medicine, Vol 11, Iss 392, p 392 (2021)
Journal of Personalized Medicine
Volume 11
Issue 5

Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn activity has been recently ident

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::23b56bc3a27708084414a936297316af
https://pub.dzne.de/record/157778